Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake

Sialic acid‐binding immunoglobulin‐like lectins (siglecs) are expressed predominantly in the haemopoietic and immune systems and exhibit specificities for both the linkage and the nature of sialic acids in N‐glycans, O‐glycans and glycolipids. Several siglecs, including sialoadhesin (Sn, siglec‐1) and siglec‐5, bind to NeuAcα2,3Gal, a terminal capping structure that can also be displayed on the lipopolysaccharide (LPS) of Neisseria meningitidis (Nm). In the present study, we examined the potential of siglecs expressed on cells of the immune system to function as receptors for sialylated Nm. We used sialylated and non‐sialylated LPS derivatives of two serogroups (A and B) of Nm in this study. Using recombinant chimeric soluble receptors, siglec‐transfected cell lines and macrophages from wild‐type and Sn‐deficient mice, we observed that sialylated but not non‐sialylated variants of either genetic background were specifically recognized by Sn and siglec‐5, whereas other siglecs examined were ineffective. In addition, macrophages expressing Sn, as well as transfectants expressing Sn or siglec‐5, bound and phagocytosed sialylated bacteria in a siglec‐ and sialic acid‐dependent manner. This study demonstrates that Nm LPS sialylation can lead to increased bacterial susceptibility to phagocytic uptake, a phenomenon in direct contrast to previously reported protective effects of LPS sialylation.

[1]  B. Bochner,et al.  Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. , 2003, Blood.

[2]  S. Watt,et al.  Human Siglec‐5: tissue distribution, novel isoforms and domain specificities for sialic acid‐dependent ligand interactions , 2002, British journal of haematology.

[3]  T. Kodama,et al.  The Class A Macrophage Scavenger Receptor Is a Major Pattern Recognition Receptor for Neisseria meningitidis Which Is Independent of Lipopolysaccharide and Not Required for Secretory Responses , 2002, Infection and Immunity.

[4]  P. Crocker,et al.  Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. , 2002, Current opinion in structural biology.

[5]  S. Royle,et al.  Identification of a Non-canonical Tyrosine-based Endocytic Motif in an Ionotropic Receptor* 210 , 2002, The Journal of Biological Chemistry.

[6]  T. Yamaji,et al.  A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to α2,8-Disialyl and Branched α2,6-Sialyl Residues , 2002, The Journal of Biological Chemistry.

[7]  P. Zhu,et al.  Influence of the Length of the Lipooligosaccharide α Chain on Its Sialylation in Neisseria meningitidis , 2002, Infection and Immunity.

[8]  A. Varki,et al.  Siglecs, sialic acids and innate immunity. , 2001, Trends in immunology.

[9]  P. Moore,et al.  Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. , 2001, The Biochemical journal.

[10]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[11]  P. Crocker,et al.  Siglec-9, a Novel Sialic Acid Binding Member of the Immunoglobulin Superfamily Expressed Broadly on Human Blood Leukocytes* , 2000, The Journal of Biological Chemistry.

[12]  A. Varki,et al.  Cloning, Characterization, and Phylogenetic Analysis of Siglec-9, a New Member of the CD33-related Group of Siglecs , 2000, The Journal of Biological Chemistry.

[13]  J. Griffiss,et al.  Structural Relationships and Sialylation among Meningococcal L1, L8, and L3,7 Lipooligosaccharide Serotypes* , 2000, The Journal of Biological Chemistry.

[14]  A. Varki,et al.  New Aspects of Siglec Binding Specificities, Including the Significance of Fucosylation and of the Sialyl-Tn Epitope* , 2000, The Journal of Biological Chemistry.

[15]  P. Klenerman,et al.  Identification and Characterization of a Novel Siglec, Siglec-7, Expressed by Human Natural Killer Cells and Monocytes* , 1999, The Journal of Biological Chemistry.

[16]  A. Varki,et al.  Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. , 1999, Glycobiology.

[17]  M. Frosch,et al.  Mechanisms of neisserial serum resistance , 1999, Molecular microbiology.

[18]  M. Augustus,et al.  Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. , 1998, Blood.

[19]  Wilbur H. Chen,et al.  Characterization of terminal NeuNAcα2–3Galβ1-4GlcNAc sequence in lipooligosaccharides of Neisseria meningitidis , 1998 .

[20]  A. May,et al.  Crystal structure of the N-terminal domain of sialoadhesin in complex with 3' sialyllactose at 1.85 A resolution. , 1998, Molecular cell.

[21]  M. Gilbert,et al.  Characterization of a Recombinant Neisseria Meningitidesα-2,3-Sialyltransferase and its Acceptor Specificity , 1997 .

[22]  M. Virji,et al.  Phenotypic variants of meningococci and their potential in phagocytic interactions: the influence of opacity proteins, pili, PilC and surface sialic acids. , 1997, Microbial pathogenesis.

[23]  H. D. Hochstein,et al.  Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity , 1997, Infection and immunity.

[24]  J. Brisson,et al.  Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes. , 1997, Carbohydrate research.

[25]  M. Virji,et al.  The N‐domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae , 1996, Molecular microbiology.

[26]  Ende,et al.  Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens , 1996, Infection and immunity.

[27]  D. Hood,et al.  Molecular analysis of a locus for the biosynthesis and phase‐variable expression of the lacto‐N‐neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis , 1995, Molecular microbiology.

[28]  D. Ferguson,et al.  Opc‐ and pilus‐dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides , 1995, Molecular microbiology.

[29]  P. Crocker,et al.  Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. , 1995, Blood.

[30]  S. Gordon,et al.  Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin‐like domains. , 1994, The EMBO journal.

[31]  E. Moxon,et al.  Distinct mechanisms of interactions of Opc‐expressing meningococci at apical and basolateral surfaces of human endothelial cells; the role of integrins in apical interactions , 1994, Molecular microbiology.

[32]  S. Hammerschmidt,et al.  Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis , 1994, Molecular microbiology.

[33]  E. Moxon,et al.  Interactions of Neisseria meningitidis with human monocytes. , 1994, Microbial pathogenesis.

[34]  M. Achtman,et al.  Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells , 1993, Molecular microbiology.

[35]  M. Apicella,et al.  Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. , 1993, Immunobiology.

[36]  M. Achtman,et al.  Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis , 1992, Molecular microbiology.

[37]  R. Rest,et al.  Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils , 1992, Infection and immunity.

[38]  P. Campbell,et al.  Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. , 1991, Journal of immunological methods.

[39]  D. Ferguson,et al.  The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells , 1991, Molecular microbiology.

[40]  D. Shotton,et al.  Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages. , 1991, The EMBO journal.

[41]  S. Gordon,et al.  Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody , 1989, The Journal of experimental medicine.

[42]  S. Gordon,et al.  Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages , 1986, The Journal of experimental medicine.

[43]  T. Yamaji,et al.  A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9. , 2002, The Journal of biological chemistry.

[44]  D. Jackson,et al.  Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. , 2001, Blood.

[45]  C. Dehio,et al.  Host cell invasion by pathogenic Neisseriae. , 2000, Sub-cellular biochemistry.

[46]  D. Stephens,et al.  Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). , 1998, Critical reviews in microbiology.

[47]  C. Tsai,et al.  Characterization of terminal NeuNAcalpha2-3Galbeta1-4GlcNAc sequence in lipooligosaccharides of Neisseria meningitidis. , 1998, Glycobiology.

[48]  M. Gilbert,et al.  Characterization of a recombinant Neisseria meningitidis alpha-2,3-sialyltransferase and its acceptor specificity. , 1997, European journal of biochemistry.

[49]  D. Ferguson,et al.  Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. , 1995, Molecular microbiology.